Systematix Corporate Services Ltd: CARE Ratings Confirms Fund Utilization Compliance

Systematix Corporate Services Ltd's preferential issue raised ₹103.12 crore. According to the latest monitoring report, ₹61.00 crore remained unutilised as of March 31, 2026.

Filing Details

Systematix Corporate Services Limited submitted its Monitoring Agency Report for the quarter ending March 31, 2026. The report, prepared by CARE Ratings Limited, confirms that funds raised from the company's preferential issue have been utilized in line with the disclosures made in the offer document. The preferential issue itself amounted to ₹103.12 crore. As of March 31, 2026, a total of ₹61.00 crore remained unutilised.

Funds raised during the issue period (October 01, 2024, to December 31, 2024) are designated for specific purposes. These include investments in subsidiaries for working capital needs, investment in Alternative Investment Funds (AIFs) as a sponsor, and general corporate purposes. The report found no material deviations in fund deployment for the quarter.

Why This Matters

This report offers assurance to investors that the company is adhering to its stated objectives for capital deployment from the preferential issue. Confirmation of compliance by an independent monitoring agency like CARE Ratings supports the company's financial management and corporate governance practices. It indicates that the company is progressing with its strategic growth plans funded by this capital.

Background

Systematix Corporate Services Limited, a diversified financial services firm, conducted a preferential issue to raise ₹103.12 crore. Shareholder approval for this issue was obtained on October 14, 2024. The funds were intended to support strategic initiatives across its business verticals, including investments in subsidiaries like Systematix Shares and Stocks (India) Limited for working capital, and launching or investing in Alternative Investment Funds (AIFs).

CARE Ratings Limited was appointed as the Monitoring Agency (MA) to track the utilization of these funds. SCSL has regularly submitted monitoring reports for various quarters, detailing fund deployment progress against approved objects.

What Changes Now

For shareholders, this report signifies that the company has met a key compliance requirement post-preferential issue, mitigating the risk of non-compliance with fund utilization norms.

The focus now shifts to the deployment of the remaining ₹61.00 crore. Investors will monitor how these funds are channeled into identified growth areas and how they contribute to the company's overall financial performance.

Risks to Watch

It is important to note the disclaimer from the Monitoring Agency. CARE Ratings states it does not perform an audit and relies on information provided by the issuer, which it believes to be reliable. The agency accepts no responsibility for any loss or damage arising from the use of this information. While the report confirms no material deviation (>10%) for the quarter, its scope is limited.

What to Track Next

• The ongoing deployment of the remaining ₹61.00 crore towards the specified objectives.
• Future Monitoring Agency Reports to track further utilization progress.
• How the investments in subsidiaries and AIFs contribute to Systematix Corporate Services Ltd.'s financial performance and strategic growth.